Viewing Study NCT06613360


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-26 @ 12:26 AM
Study NCT ID: NCT06613360
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Sponsor: Cullinan Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module